These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25238749)

  • 1. M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation.
    Gurses KM; Yalcin MU; Kocyigit D; Kesikli SA; Canpolat U; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Ozer N; Oto MA; Guc D; Aytemir K
    Europace; 2015 Feb; 17(2):239-46. PubMed ID: 25238749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Autoantibody Levels Predict Recurrence Following Cryoballoon-Based Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation Patients.
    Yalcin MU; Gurses KM; Kocyigit D; Kesikli SA; Dural M; Evranos B; Yorgun H; Sahiner L; Kaya EB; Oto MA; Guc D; Aytemir K; Ozer N
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):615-21. PubMed ID: 25788224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between vitamin D level and left atrial fibrosis in patients with lone paroxysmal atrial fibrillation undergoing cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    J Cardiol; 2017 Jan; 69(1):16-23. PubMed ID: 27554047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.
    Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated M2-muscarinic and β1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation.
    Yalcin MU; Gurses KM; Kocyigit D; Kesikli SA; Ates AH; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Oto MA; Guc D; Ozer N; Aytemir K
    Clin Res Cardiol; 2015 Mar; 104(3):226-33. PubMed ID: 25351416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.
    Hu B; Sun Y; Li S; Sun J; Liu T; Wu Z; Feng LI
    Pacing Clin Electrophysiol; 2016 Dec; 39(12):1379-1387. PubMed ID: 27862036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of pre-procedural autoantibodies against M2-muscarinic acetylcholine receptor for recurrence of atrial fibrillation one year after radiofrequency catheter ablation.
    Zou C; Zhang Z; Zhao W; Li G; Ma G; Yang X; Zhang J; Zhang L
    J Transl Med; 2013 Jan; 11():7. PubMed ID: 23294565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo.
    Hong CM; Zheng QS; Liu XT; Shang FJ; Wang HT; Jiang WR
    Cardiology; 2009; 112(3):180-7. PubMed ID: 18679026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation.
    Akkaya M; Higuchi K; Koopmann M; Burgon N; Erdogan E; Damal K; Kholmovski E; McGann C; Marrouche NF
    Europace; 2013 Dec; 15(12):1725-32. PubMed ID: 23711578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Yorgun H; Şahiner L; Kaya EB; Çay S; Topaloğlu S; Aras D; Oto A
    Europace; 2014 Dec; 16(12):1731-7. PubMed ID: 25355778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum YKL-40 as a Marker of Left Atrial Fibrosis Assessed by Delayed Enhancement MRI in Lone Atrial Fibrillation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1386-95. PubMed ID: 26256257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
    Marrouche NF; Wilber D; Hindricks G; Jais P; Akoum N; Marchlinski F; Kholmovski E; Burgon N; Hu N; Mont L; Deneke T; Duytschaever M; Neumann T; Mansour M; Mahnkopf C; Herweg B; Daoud E; Wissner E; Bansmann P; Brachmann J
    JAMA; 2014 Feb; 311(5):498-506. PubMed ID: 24496537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling.
    Yalcin MU; Gurses KM; Kocyigit D; Canpinar H; Canpolat U; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Tokgozoglu L; Oto MA; Ozer N; Guc D; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):635-40. PubMed ID: 25684038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
    Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation.
    Bisbal F; Guiu E; Calvo N; Marin D; Berruezo A; Arbelo E; Ortiz-Pérez J; de Caralt TM; Tolosana JM; Borràs R; Sitges M; Brugada J; Mont L
    J Cardiovasc Electrophysiol; 2013 Jul; 24(7):752-9. PubMed ID: 23489827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of assessment of left atrial late gadolinium enhancement in patients undergoing ablation of atrial fibrillation.
    Sramko M; Peichl P; Wichterle D; Tintera J; Weichet J; Maxian R; Pasnisinova S; Kockova R; Kautzner J
    Int J Cardiol; 2015 Jan; 179():351-7. PubMed ID: 25464485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cryoballoon-based catheter ablation on left atrial structural and potential electrical remodeling in patients with paroxysmal atrial fibrillation.
    Canpolat U; Aytemir K; Özer N; Oto A
    J Interv Card Electrophysiol; 2015 Nov; 44(2):131-9. PubMed ID: 26238480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation.
    Fredersdorf S; Ucer E; Jungbauer C; Dornia C; Eglmeier J; Eissnert C; Hamer OW; Weber S; Arzt M; von Bary C
    Europace; 2014 Jan; 16(1):26-32. PubMed ID: 23744849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Yorgun H; Şahiner L; Kaya EB; Çay S; Topaloğlu S; Aras D; Oto A
    Europace; 2015 Dec; 17(12):1807-15. PubMed ID: 25995388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation.
    den Uijl DW; Delgado V; Bertini M; Tops LF; Trines SA; van de Veire NR; Zeppenfeld K; Schalij MJ; Bax JJ
    Heart; 2011 Nov; 97(22):1847-51. PubMed ID: 21357370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.